Antecedent use of fluoroquinolones is associated with resistance to moxifloxacin in Clostridium difficile
- 1 June 2003
- journal article
- Published by Elsevier in Clinical Microbiology & Infection
- Vol. 9 (6) , 526-530
- https://doi.org/10.1046/j.1469-0691.2003.00559.x
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Resistance to Moxifloxacin in Toxigenic Clostridium difficile Isolates Is Associated with Mutations in gyrAAntimicrobial Agents and Chemotherapy, 2001
- In vitro activity of sitafloxacin against Clostridium difficile.Journal of Antimicrobial Chemotherapy, 2001
- Mechanisms Responsible for Cross-Resistance and Dichotomous Resistance among the QuinolonesClinical Infectious Diseases, 2001
- In vitro activity of new quinolones against Clostridium difficile.Journal of Antimicrobial Chemotherapy, 2001
- In vitro activity of new generation fluoroquinolones against genotypically distinct and indistinguishable Clostridium difficile isolatesJournal of Antimicrobial Chemotherapy, 2000
- Persistence of an Endemic (Toxigenic) Isolate of Clostridium difficile in the Environment of a General Medicine WardClinical Infectious Diseases, 2000
- Antibiotics andMicrobes and Infection, 1999
- Expanded activity and utility of the new fluoroquinolones: A reviewClinical Therapeutics, 1999
- Influence of Low Dose Ciprofloxacin on Microbial Colonization of the Digestive Tract in Healthy Volunteers During Normal and During Impaired Colonization ResistanceScandinavian Journal of Infectious Diseases, 1997
- Clostridium difficile ColitisNew England Journal of Medicine, 1994